drugset

drugset / Trial / NCT00200512

Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months

NCT00200512 ↗

Phase 2/3 Completed 16 enrolled Mylan Bertek Pharmaceuticals

RandomizedCrossoverDouble-blindTreatment

Summary

The objective of this study was to measure the continued efficacy of apomorphine after previous exposure of at least three months duration.

Timeline

Start: 1999-09
Primary completion: —
Completion: 1999-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Apomorphine	Unknown	—	Subcutaneous

Indications